Cell‐free DNA for detection and monitoring of extramedullary AML relapse

Cell‐free DNA for detection and monitoring of extramedullary AML relapse

Abstract Isolated extramedullary manifestations (IEM) of acute myeloid leukemia (AML) are recurrent events, especially following allogeneic hematopoietic cell transplantation (alloHCT). To date, measurable residual disease (MRD) assessment for this difficult‐to‐treat patient cohort has not been esta...

Full description

Saved in:
Bibliographic Details
Main Authors: Henri C. Hupe, Clara P. Wienecke, Stephan Bartels, Elisa Schipper, Jannika Leßmann, Alina Lasch, Maximilian Bader, Razif Gabdoulline, Martin Neugebohren, Elke Dammann, Hans H. Kreipe, Ulrich Lehmann, Anke K. Bergmann, Nataliya Di Donato, Michael Stadler, Matthias Eder, Arnold Ganser, Florian H. Heidel, Felicitas Thol, Michael Heuser
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:HemaSphere
Online Access:https://doi.org/10.1002/hem3.70097
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/hem3.70097

Similar Items